Content about Peripheral neuropathy

November 8, 2013

Topical BioMedics recently gained distribution for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.

RHINEBECK, N.Y. — Topical BioMedics recently gained distribution for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics. The cream has been specially formulated to address issues associated with foot and ankle pain and injuries.

October 8, 2013

Topical BioMedics recently announced distribution through CVS/pharmacy for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.

RHINEBECK, N.Y. — Topical BioMedics recently announced distribution through CVS/pharmacy for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.

November 1, 2012

The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.

FARMINGTON, Conn. – The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.

Global Information announced the availability of four research reports that analyze the global markets for treatments for syndromes of progressive ataxia and weakness disorders. According to GII, the global market for treatments was nearly $14 billion and is expected to reach $23.5 billion by 2017, after increasing at a five-year compound annual growth rate of 9.4%.

August 29, 2012

The Food and Drug Administration has approved a supplemental new drug application for an opioid analgesic to treat diabetes-related pain.

RARITAN, N.J. — The Food and Drug Administration has approved a supplemental new drug application for an opioid analgesic to treat diabetes-related pain.

July 5, 2012

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

BALTIMORE — The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

Lupin announced the approval of pregabalin capsules in the 25-mg, 50-mg, 75-mg, 100-mg, 150-mg, 200-mg, 225-mg and 300-mg strengths. The drug is used to treat fibromyalgia, partial-onset seizures in adults, neuropathic pain associated with diabetic peripheral neuropathy and post-herpetic neuralgia.

October 31, 2011

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

TITUSVILLE, N.J. — A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

June 17, 2011

Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

WALTHAM, Mass. — Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

Nipro and NeuroMetrix said the NC-stat DPNCheck test, developed by NeuroMetrix, could offer a cost-effective approach to detecting and monitoring DPN, which affects more than half of people with diabetes and could lead to such conditions as foot ulcers and limb amputation.

The companies currently are evaluating opportunities for the NC-stat DPNCheck in retail medical clinics.

July 19, 2010

Drug maker Pfizer is suspending some clinical studies of a biotech drug for treating pain...